Recherche
Enseignement
Solutions
S'identifier
FR
EN - English
CN - 中文
DE - Deutsch
ES - Español
KR - 한국어
IT - Italiano
FR - Français
PT - Português
TR - Turkish
JA - Japanese
Department of Pathology
Eva Hernando has not added Biography.
If you are Eva Hernando and would like to personalize this page please email our Author Liaison for assistance.
Epigenetic Silencing of CDR1as Drives IGF2BP3-Mediated Melanoma Invasion and Metastasis.
Cancer cell 01, 2020 | Pubmed ID: 31935372
Regulates the Proliferation Capacity of Bone-Marrow Derived Mesenchymal Stem Cells.
Cells 09, 2020 | Pubmed ID: 32927859
The State of Melanoma: Emergent Challenges and Opportunities.
Clinical cancer research : an official journal of the American Association for Cancer Research 05, 2021 | Pubmed ID: 33414132
Treatment with therapeutic anticoagulation is not associated with immunotherapy response in advanced cancer patients.
Journal of translational medicine 01, 2021 | Pubmed ID: 33516263
Network models of primary melanoma microenvironments identify key melanoma regulators underlying prognosis.
Nature communications 02, 2021 | Pubmed ID: 33619278
NYU Grossman School of Medicine
Perlmutter Cancer Center
Arman Alberto Sorin Shadaloey1,2,
Alcida Karz1,2,
Rana S. Moubarak1,2,
Praveen Agrawal1,2,
Grace Levinson1,2,
Kevin Kleffman1,2,
Orlando Aristizabal3,4,
Iman Osman2,5,
Youssef Z. Wadghiri3,4,
Eva Hernando1,2
1Department of Pathology, NYU Grossman School of Medicine,
2Interdisciplinary Melanoma Cooperative Group, Perlmutter Cancer Center,
3Department of Radiology, NYU Grossman School of Medicine,
4Preclinical Imaging Core, NYU Grossman School of Medicine,
5Ronald Perelman Department of Dermatology, NYU Grossman School of Medicine
Confidentialité
Conditions d'utilisation
Politiques
Contactez-nous
RECOMMANDER À LA BIBLIOTHÈQUE
NEWSLETTERS JoVE
JoVE Journal
Collections de méthodes
JoVE Encyclopedia of Experiments
Archives
JoVE Core
JoVE Business
JoVE Science Education
JoVE Lab Manual
Centre de ressources universitaires
Auteurs
Bibliothécaires
Accès
À PROPOS DE JoVE
Copyright © 2024 MyJoVE Corporation. Tous droits réservés.